Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma

NIH RePORTER · NIH · R01 · $71,810 · view on reporter.nih.gov ↗

Abstract

The supplement instructions PA‐21-071 state: “At minimum, the Research Strategy section should be completed and must include a summary or abstract of the funded parent award or project. Other sections should also be included if they are being changed by the proposed supplement activities.” The original Project Summary document has not changed as a result of the proposed supplement activities.

Key facts

NIH application ID
10406778
Project number
3R01NS109423-02S1
Recipient
UNIVERSITY OF CALIFORNIA-IRVINE
Principal Investigator
Daniela Annenelie Bota
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$71,810
Award type
3
Project period
2020-09-01 → 2025-05-31